Noreen Ersing
Overview
Explore the profile of Noreen Ersing including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
120
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chitta K, Khan A, Ersing N, Swaika A, Masood A, Paulus A, et al.
Leuk Lymphoma
. 2013 Jun;
55(3):652-61.
PMID: 23721511
Chronic lymphocytic leukemia (CLL) is the most common adult leukemia and is currently incurable. To expand the therapeutic armamentarium, we investigated neem leaf extract (NLE) after a patient with CLL...
2.
Masood A, Chitta K, Paulus A, Khan A, Sher T, Ersing N, et al.
Br J Haematol
. 2011 Dec;
157(1):59-66.
PMID: 22171982
Over-expression of anti-apoptotic BCL2 has been reported in chronic lymphocytic leukaemia (CLL), but targeting BCL2 alone did not yield appreciable clinical results. However, it was demonstrated that BCL2 inhibitors enhanced...
3.
Chanan-Khan A, Chitta K, Ersing N, Paulus A, Masood A, Sher T, et al.
Br J Haematol
. 2011 Oct;
155(4):457-67.
PMID: 22010965
Lenalidomide has demonstrated impressive antileukaemic effects in patients with chronic lymphocytic leukaemia (CLL). The mechanism(s) by which it mediates these effects remain unclear. Clinically, CLL patients treated with lenalidomide demonstrate...
4.
Ghoshal P, Nganga A, Moran-Giuati J, Szafranek A, Johnson T, Bigelow A, et al.
Cancer Res
. 2009 May;
69(10):4380-7.
PMID: 19417136
Multiple myeloma (MM) is a clonal B-cell neoplasm that accounts for 10% of all malignant hematologic neoplasms and that affects terminally differentiated B cells (i.e., plasma cells). It is now...
5.
Harrigan J, Vezina C, McGarrigle B, Ersing N, Box H, Maccubbin A, et al.
Toxicol Sci
. 2003 Dec;
77(2):307-14.
PMID: 14691214
Chemical-DNA adducts provide an integrated measure of exposure, absorption, bioactivation, detoxification, and DNA repair following exposure to a genotoxic agent. Benzo[a]pyrene (BaP), a prototypical polycyclic aromatic hydrocarbon (PAH), can be...